Search Results - "Bozkaya, D."

Assessing Prescription Drug Value In The United States: A Hypothetical Example Comparing Asco And Icer Framework Outcomes by Bozkaya, D, Migliaccio-Walle, K, O’Day, K

Get full text

Estimation of the Budget impact of Rifaximin treatment in patients with Irritable Bowel Syndrome by Bozkaya, D, Barrett, A.C, Migliaccio-Walle, K

Get full text

Rifaximin and Eluxadoline Utilization for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the United States and Budget Impact Analysis of Switching from Eluxadoline to Rifaximin by Bloudek, LM, Bozkaya, D, O'Hara, K, Kirby, SK, Shah, S

Get full text

Transient hypertrophic pyloric stenosis due to prostoglandin infusion by Soyer, T, Yalcin, S, Bozkaya, D, Yiğit, Ş, Tanyel, F C

“…Prostaglandin E1 (PGE1) is widely used in ductus-dependant congenital heart disease to maintain the patency of ductus. Hypertrophic pyloric stenosis (HPS) due…”
Get full text

The Cost-Effectiveness of Disease Modifying Therapies for The Treatment of Relapsing-Remitting Multiple Sclerosis by Bozkaya, D, Livingston, T.P, Migliaccio-Walle, K, Mehta, S, Odom, T

Get full text

Evaluation of Patient and Financial Outcomes Associated With Advanced Infertility Treatment Options by Locklear, J, Bozkaya, D, Migliaccio, K, Bramley, T, Phillips, A.L, Mahony, M

Get full text

The role of mean platelet volume as an inflammatory marker in children with chronic spontaneous urticaria by Akelma, A Z, Mete, E, Cizmeci, M N, Kanburoglu, M K, Malli, D D, Bozkaya, D

“…Previous studies have shown that platelets are involved in the inflammatory process. Mean platelet volume (MPV) has been frequently used as an inflammatory…”
Get more information

Elevated level of serum osteopontin in school-age children with asthma by Akelma, A Z, Cizmeci, M N, Kanburoglu, M K, Bozkaya, D, Catal, F, Mete, E, Kutukoglu, I, Namuslu, M

“…The role of osteopontin (OPN) has not been elucidated in childhood asthma. Our purpose was to investigate whether OPN levels change due to allergic…”
Get more information

PCN33 COST SAVINGS ASSOCIATED WITH TRANSFUSION INDEPENDENCE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH A 5Q- DELETION by Bozkaya, D, Mahmoud, D, Mitsi, G, Khan, Z.M

Get full text

Projected Savings in Direct and Indirect Costs Due to Reduced Diabetes Prevalence with Vegetarian Diets by Bozkaya, D

Get full text

PDB37 - Projected Savings in Direct and Indirect Costs Due to Reduced Diabetes Prevalence with Vegetarian Diets by Bozkaya, D

Get full text

343 Cost-effectiveness of deferasirox in lower-risk myelodysplastic syndrome (MDS) in Canada by El Ouagari, K, Migliaccio-Walle, K, Lau, H, Bozkaya, D

Get full text

Cost effectiveness of deferasirox compared to desferrioxamine in the treatment of iron overload in lower-risk, transfusion-dependent myelodysplastic syndrome patients by Tolley, K, Oliver, N, Miranda, E, Migliaccio-Walle, K, Bozkaya, D, Li, Q

“…The study evaluated the cost effectiveness of deferasirox (Exjade * ) compared to non-proprietary desferrioxamine (DFO) for the control of transfusional iron…”
Get more information

PMH18 THE IMPLEMENTATION OF COMPETING RISKS USING DIFFERENT MODELING TECHNIQUES AND STRUCTURES: THE EFFECT ON INCREMENTAL COST-EFFECTIVENESS by Bozkaya, D., O'Day, K.

Get full text

EE378 Targeted Literature Review of Non-Payer Costing in Societal-Perspective Oncology Cost Effectiveness Models by Beaulieu, E., Bozkaya, D., Muston, D.

Get full text

EE43 Understanding the Humanistic and Economic Burden Associated with Early-Stage HR+/HER2- Breast Cancer: A Systematic Literature Review by Earla, JR, Singh, P, Bozkaya, D, Nathani, J, Pandey, P, Haiderali, A

Get full text

CN1 - The Economic Impact of Switching to Trastuzumab Biosimilar for the Treatment of Metastatic Breast Cancer from a Chinese Payer Perspective by Liu, S, Bozkaya, D, Brown, D

Get full text

The Economic Impact of Switching to Trastuzumab Biosimilar for the Treatment of Metastatic Breast Cancer from a Chinese Payer Perspective by Liu, S, Bozkaya, D, Brown, D

Get full text

PCR124 Patient-Reported Impact of Choroideremia on Daily Activities, Work Activities, and Healthcare Resource Utilization by Thompson, J, Balkaran, B, Altenweg, D, Flomenhoft, J, Yanonis, A, Bozkaya, D

Get full text

PCN74 - The Economic Impact of Switching To Herceptin (TRASTUZUMAB) Biosimilar for The Treatment of Metastatic Breast Cancer From A UK Payer Perspective by Brown, D, Bozkaya, D, Xcenda, LLC

Get full text